| abstract |
The invention describes anti-PD-L1 antibodies and antigen-binding fragments thereof. The invention also describes nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of making the antibodies, and methods of using the antibodies to treat or prevent diseases, such as cancer, infectious diseases, and autoimmune diseases. |